Log In Sign up
The largest database of trusted experimental protocols

Dalfampridine

Manufactured by Merck Group
Visit Supplier

Dalfampridine is a pharmaceutical compound developed by Merck Group. It is a potassium channel blocker with the primary function of improving nerve impulse transmission. The product is intended for use in laboratory settings for research and development purposes.

Automatically generated - may contain errors

Lab products found in correlation

Cilengitide, by Selleck Chemicals (2 mentions) Guanidine hcl, by Merck Group (2 mentions) Abt 199, by Selleck Chemicals (2 mentions) Wnk463, by Selleck Chemicals (2 mentions) Birinapant, by Selleck Chemicals (2 mentions) Anti il 9, by R&D Systems (2 mentions) Bez235, by Selleck Chemicals (2 mentions) Xct790, by Merck Group (2 mentions) Fomepizole, by Selleck Chemicals (2 mentions) Chr2797, by Bio-Techne (2 mentions) Topiramate, by Selleck Chemicals (2 mentions) Almorexant, by Selleck Chemicals (2 mentions) Sb334867, by R&D Systems (2 mentions) Anti il1r1, by R&D Systems (2 mentions) S17092, by Merck Group (2 mentions) Lcl161, by Selleck Chemicals (2 mentions) Anti itgav, by Abcam (2 mentions) Abt 263, by Selleck Chemicals (2 mentions) Apitolisib, by Selleck Chemicals (2 mentions)

2 protocols using dalfampridine

1

Inhibitor Procurement and Utilization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibitors were purchased from commercial suppliers as listed below, or were provided (Compound 29, (Patch et al., 2011 (link))) by the Donald McDonnell Laboratory (Duke University). ABT199 (Selleckchem #S8048), ABT263 (Selleckchem #S1001), LCL161 (Selleckchem #S7009), Birinapant (Selleckchem #S7015), Fomepizole (Selleckchem #S1717), CHR2797 (Tocris #3595), XCT790 (Sigma Aldrich #X4753), Topiramate (Selleckchem #S1438), ACET (Tocris #2728), Almorexant (Selleckchem #S2160), SB334867 (R&D Systems, #1960), anti-IL1R1 (R&D Systems, #AF269), anti-IL9 (R&D Systems, #AF209), anti-ITGAV (Abcam, #ab16821), Cilengitide (Selleckchem, #S7077), Guanidine HCl (Sigma Aldrich, #G3272), Dalfampridine (Sigma Aldrich, #275875), BEZ235 (Selleckchem, #S1009), Apitolisib (Selleckchem, #S2696), S17092 (Sigma Aldrich, #SML0181), WNK463 (Selleckchem, #S8358).
Kishton R.J., Patel S.J., Decker A.E., Vodnala S.K., Cam M., Yamamoto T.N., Patel Y., Sukumar M., Yu Z., Ji M., Henning A.N., Gurusamy D., Palmer D.C., Stefanescu R.A., Girvin A.T., Lo W., Pasetto A., Malekzadeh P., Deniger D.C., Wood K.C., Sanjana N.E, & Restifo N.P. (2022). Cancer genes disfavoring T cell immunity identified via integrated systems approach. Cell reports, 40(5), 111153.
+ Open protocol
+ Expand
2

Inhibitor Procurement and Utilization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibitors were purchased from commercial suppliers as listed below, or were provided (Compound 29, (Patch et al., 2011 (link))) by the Donald McDonnell Laboratory (Duke University). ABT199 (Selleckchem #S8048), ABT263 (Selleckchem #S1001), LCL161 (Selleckchem #S7009), Birinapant (Selleckchem #S7015), Fomepizole (Selleckchem #S1717), CHR2797 (Tocris #3595), XCT790 (Sigma Aldrich #X4753), Topiramate (Selleckchem #S1438), ACET (Tocris #2728), Almorexant (Selleckchem #S2160), SB334867 (R&D Systems, #1960), anti-IL1R1 (R&D Systems, #AF269), anti-IL9 (R&D Systems, #AF209), anti-ITGAV (Abcam, #ab16821), Cilengitide (Selleckchem, #S7077), Guanidine HCl (Sigma Aldrich, #G3272), Dalfampridine (Sigma Aldrich, #275875), BEZ235 (Selleckchem, #S1009), Apitolisib (Selleckchem, #S2696), S17092 (Sigma Aldrich, #SML0181), WNK463 (Selleckchem, #S8358).
Kishton R.J., Patel S.J., Decker A.E., Vodnala S.K., Cam M., Yamamoto T.N., Patel Y., Sukumar M., Yu Z., Ji M., Henning A.N., Gurusamy D., Palmer D.C., Stefanescu R.A., Girvin A.T., Lo W., Pasetto A., Malekzadeh P., Deniger D.C., Wood K.C., Sanjana N.E, & Restifo N.P. (2022). Cancer genes disfavoring T cell immunity identified via integrated systems approach. Cell reports, 40(5), 111153.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!